# Rhythm made $195M and lost $202M. Then the tariff clock started. - Date: 2026-04-13 - Category: Biotech & Life Sciences Rhythm posted $195M in 2025 revenue and still lost $202M. The FDA just approved its drug for 29,000 more patients. Then the 100% tariff clock started running, and the company has no MFN deal to slow it down. ---